Dr. Arya Sharma highlights the most important weight loss tip everyone should know and why weight maintenance is a major achievement.

Over the course of their lifetimes, roughly half of all people with diabetes develop diabetic neuropathy, which affects the nerves and can cause feelings of numbness and...

For Valentine’s Day, we are asking you to consider extending your love to children who have diabetes but who don’t have access to treatment and medicine. This week,...

Gary Scheiner searches for the happy medium between neglecting your diabetes care and being completely overwhelmed.

(S)he said what!?

On September 13, the New York City Board of Health approved Mayor Michael Bloomberg’s proposed regulation nearly unanimously. The regulation bans the sale of any soda or...

Friends for Life, the national Children with Diabetes (CWD) conference, took place in Orlando, Florida, from July 11 to July 15.

On March 1, Vivus started its Save Now! program, which sets a discounted price of $75 for one 30-day supply of the company’s weight management medication Qsymia (7.5 mg...

(S)he said what!?

To mark the end of this month’s 72nd American Diabetes Association (ADA) Scientific Sessions in Philadelphia (see conference pearls in this issue), diaTribe editor in...

On November 28, CeQur announced that it had received CE Mark approval for its PaQ Insulin Delivery Device , allowing the product to be sold in Europe. The Swiss-based...

Jim Hirsch sheds light on the shocking conditions an inmate with type 1 diabetes is enduring while behind bars. You can help him by signing our petition to protest this...

Can a drug for type 2 diabetes work for those with type 1? How will a new basal insulin compare to Lantus?

Wireless, cell phone-enabled, and data-to-the-cloud glucose meters are a new trend in diabetes, evidenced by the recent launch of Sanofi’s iBGStar (see test drive in...

On February 8, Novo Nordisk received an FDA complete response letter (CRL) for Tresiba (insulin degludec) and Ryzodeg (insulin degludec/aspart). Tresiba is Novo Nordisk’...

The newest in CGM: learn about Dexcom’s redesigned, more accurate, and sleeker G4 Platinum system.

James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .

In time for the beginning of this school year, DC Public Schools (DCPS) took a major step toward providing access to essential care for all its students with diabetes...

We like Practical Diabetology because it's straightforward, actionable, and smart — but, be warned, it's for physicians.

On July 17, the FDA approved Vivus’ weight-loss medication Qsymia (formerly called Qnexa), just several weeks after the approval of Arena’s Belviq (see new now next in...